GLUL and Alzheimer disease: Furthermore, research in AD patients has shown reduced activity of astrocytic glutamine synthetase and increased activity of adenosine monophosphate deaminase, which hydrolyzes AMP to inosine monophosphate and ammonia, suggesting an abnormal ammonia metabolism in the AD brain (12, 13).